Scientists at McMaster have identified new biomarkers for Irritable Bowel Syndrome (IBS) in urine, which could lead to better treatments and reduce the need for costly and invasive colonoscopy procedures currently used for diagnosis.
Chemists at McMaster have discovered new signatures that could identify cystic fibrosis in infants sooner with better reliability.